Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Sara Sheikhbahaei"'
Autor:
Rathan M. Subramaniam, Veeresh Kumar N. Shivamurthy, Greg Avey, Charles Marcus, Sara Sheikhbahaei
Publikováno v:
Radiologic Clinics of North America. 59:773-788
Head and neck cancers are commonly encountered cancers in clinical practice in the United States. Fluorine-18-fluorodeoxyglucose (18F-FDG) PET/CT has been clinically applied in staging, occult primary tumor detection, treatment planning, response ass
Publikováno v:
PET clinics. 17(2)
Publikováno v:
Clinical lung cancer. 21(6)
This review covers the state-of-the-art imaging in therapy assessment and surveillance of lung cancer with focus on the utility of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (
Autor:
Lilja B. Solnes, Mehrbod S. Javadi, Constantin Lapa, Steven P. Rowe, Mohamad E. Allaf, Michael A. Gorin, Martin G. Pomper, Krystyna M. Jones, Andreas K. Buck, Takahiro Higuchi, Ashley E. Ross, Kenneth J. Pienta, Sara Sheikhbahaei, Rudolf A. Werner
Publikováno v:
Annals of Nuclear Medicine
Objective: Radiotracers targeting prostate-specific membrane antigen (PSMA) have increasingly been recognized as showing uptake in a number of normal structures, anatomic variants, and non-prostate-cancer pathologies. We aimed to explore the frequenc
Autor:
Se J. Ahn, Sara Sheikhbahaei, Rathan M. Subramaniam, Charles Marcus, Mehdi Taghipour, Brenda Young
Publikováno v:
Nuclear Medicine Communications. 38:720-725
This study aimed to evaluate the comparative effectiveness of follow-up fluorine-18-fluorodeoxyglucose (F-FDG)-PET/CT and chest CT in the detection of local, regional, and distant metastatic diseases in lung cancer.Follow-up F-FDG-PET/CT and chest-CT
Autor:
Esther Mena, Arman Rahmim, Abhinav K. Jha, Lilja Solnes, Rathan M. Subramaniam, Mehdi Taghipour, Sara Sheikhbahaei
Publikováno v:
Clinical Nuclear Medicine. 42:e227-e234
The aim of this study was to evaluate the impact of intratumoral metabolic heterogeneity and quantitative FDG PET/CT imaging parameters for predicting patient outcomes in primary oropharyngeal squamous cell cancer (OPSCC).We retrospectively investiga
Publikováno v:
Nuclear Medicine Communications. 37:602-608
To evaluate the accuracy and value of the fourth and subsequent post-therapy follow-up fluorine-18 fluorodeoxyglucose (F-FDG) PET/computed tomography (CT) scans in the clinical assessment of breast cancer patients.Ninety-two female patients, with a t
Autor:
Sara, Sheikhbahaei, Esther, Mena, Puskar, Pattanayak, Mehdi, Taghipour, Lilja B, Solnes, Rathan M, Subramaniam
Publikováno v:
PET clinics. 12(1)
A variety of methods have been developed to assess tumor response to therapy. Standardized qualitative criteria based on 18F-fluoro-deoxyglucose PET/computed tomography have been proposed to evaluate the treatment effectiveness in specific cancers an
Autor:
Esther Vicente, Rathan M. Subramaniam, Mehdi Taghipour, Jennifer Xiao, Sara Sheikhbahaei, Abhinav K. Jha, Esther Mena
Publikováno v:
Clinical nuclear medicine. 42(1)
We aimed to determine the consistency of quantitative PET measurements of metabolic tumor volume (MTV) and intratumoral heterogeneity index for primary untreated pancreatic adenocarcinomas, when using dual-time point F-FDG PET/CT imaging.This is an i
The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer
Autor:
Esther Mena, Siddaling Reddy, Jason W Wachsmann, Anusha Yanamadala, Lilja Solnes, Sara Sheikhbahaei, Rathan M. Subramaniam
Publikováno v:
AJR. American journal of roentgenology. 208(2)
OBJECTIVE. The purpose of this article is to summarize the evidence regarding the role of FDG PET/CT in treatment response assessment and surveillance of lung cancer and to provide suggested best practices. CONCLUSION. FDG PET/CT is a valuable imagin